Home › Research › Tau biomarkers
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien, Shadfar Bahri, Anna Katrin Szardenings, Joseph C. Walsh, Fanrong Mu, Min‐Ying Su, William Rodman Shankle, Arkadij M. Elizarov, Hartmuth Christian Kolb. Journal of Alzheimer s Disease, 2013-06-20
Topic: Brain proteins, microglia and lab models
Plain-language summary
Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease. We have developed a novel PHF-tau targeting positron emission tomography imaging agent, [F-18]-T807, which may be useful for imaging Alzheimer's disease and other tauopathies. Here in, we describe the first human brain images with [F-18]-T807.
What this study adds
Evidence grade: Not rated
The authors describe the first human brain images with [F-18]-T807, a PET imaging agent they developed to target aggregated tau (PHF-tau). They say it may be useful for imaging Alzheimer's disease and other tauopathies.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Chien, D. T., Bahri, S., Szardenings, A. K., Walsh, J. C., Mu, F., Su, M., et al. (2013). Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-122059
Vancouver
Chien DT, Bahri S, Szardenings AK, Walsh JC, Mu F, Su M, et al. Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807. Journal of Alzheimer s Disease. 2013. doi:10.3233/jad-122059. PMID: 23234879.
BibTeX
@article{chien2013-23234879,
author = {Chien, David T. and Bahri, Shadfar and Szardenings, Anna Katrin and Walsh, Joseph C. and Mu, Fanrong and Su, Min‐Ying and Shankle, William Rodman and Elizarov, Arkadij M. and Kolb, Hartmuth Christian},
title = {{Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807}},
journal = {Journal of Alzheimer s Disease},
year = {2013},
doi = {10.3233/jad-122059},
pmid = {23234879},
url = {https://doi.org/10.3233/jad-122059}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 9 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Why it matters
The authors describe the first human brain images with [F-18]-T807, a PET imaging agent they developed to target aggregated tau (PHF-tau). They say it may be useful for imaging Alzheimer's disease and other tauopathies.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
How this study scored 48/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on strength of evidence, so that was left out: it earned 46 of the 95 points we could judge it on, which is 48 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Alzheimer s Disease) |
| Journal's citation record | 2 / 4 | Journal of Alzheimer s Disease: journal h-index 218 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | — / 5 | No evidence rating recorded — left out of this score |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2013 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 653 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 43.5 citations a year over 15 year(s) since 2013 |
| Impact for its field and year | 6 / 6 | Cited 46.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 3 / 4 | Cited 58 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Hartmuth Christian Kolb: h-index 65 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of California, Irvine: institution h-index 1,195 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 23234879) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 46 / 95 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 46 of the 95 points we could judge it on is 48 out of 100. |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Tau biomarkers from nearby years
Also tagged “phosphorylated”
733 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 733 tagged studies.